Cause:(BMJ 2004;329:962) Immature lungs from premature delivery, often exacerbated by maternal diabetes (Nejm 1976;294:357)
Pathophys:Surfactant deficiency or inhibition allows collapse of alveoli; plasma exudate forms membrane (Nejm 1971;284:1185)
Incidence incr w prematurity, Caucasian race, male gender, maternal diabetes, c-section, hypothermia, 2nd twin, perinatal asphyxia, previous infant with RDS; 60% under 30 weeks gestation; 5% over 34 weeks
Sx:Onset 0-4 h postpartum
Si:Grunting respirations, tachypnea, intercostal retractions, atelectasis, ductus murmur, flaring
Bronchopulmonary dysplasia chronic lung disease in many from O2 rx with scarring, and barotrauma (Nejm 1990;323:1793), perhaps helped w inhaled steroids (Nejm 1999;340:1005, 1036); pneumothorax; diaphragmatic hernia; patent ductus arteriosus, esp with fluid overload (Nejm 1983;308:743), rx with indomethacin (Nejm 1984;310:565); retinopathy of prematurity, esp in low-birth-weight (<1 kg) premies exposed to high light levels in NICUs (Nejm 1985;313:401) or 100% O2 levels w pO2 levels >80 mm Hg for >12 h (Nejm 1992;326:1050)
r/o TTN (transient tachypnea of newborn), a benign and common condition; group B strep and other infections; congenital heart disease and other anomalies
Lab:
Chem:Blood gases show respiratory acidosis, hypoxia; suspect if FiO2 requirement >40%
Xray:Chest shows air bronchograms, ground glass appearance
Rx:
Prevent w steroids between 28-32 weeks if threatened premature delivery, >24 h but <7 days prior to delivery, × 1 but not repeated (Nejm 2008;357:1179, 1190, 1248); but not helpful for low-birth-weight infants (Nejm 2001;344:95). Avoid steroids postpartum because diminishes school performance eventually (Nejm 2004;350:1304)
Prophylaxis:
Support by keeping warm (hypothermia causes bronchoconstriction); D10W at 80-160 cc/kg/24 h to maintain glucose homeostasis, may need volume infusions to maintain BP or perfusion; continuous positive airway pressure (CPAP) or low-volume high frequency jet ventilation breathing via endotrach tube with surfactant (Nejm 1994;331:1051) or liquid perflubron (Nejm 1996;335:761); w nitric oxide? (Nejm 2006;355:343)